PROGNOSTIC SIGNIFICANCE OF TONSL EXPRESSION AND THE HOMOLOGOUS RECOMBINATION PATHWAY IN INTERMEDIATE-RISK PROSTATE CANCER RECURRENCE

被引：0

作者：

So, Jonathan ^{[1
]}

Chua, Melvin ^{[2
]}

Lalonde, Emilie ^{[3
]}

Mahamud, Osman ^{[1
]}

Berlin, Alejandro ^{[1
]}

Dal Pra, Alan ^{[4
]}

Orain, Michele ^{[5
]}

Hovington, Helene ^{[6
]}

Bergeron, Alain ^{[6
]}

Fradet, Yves ^{[6
]}

Tetu, Bernard ^{[5
]}

Meng, Alice ^{[2
]}

Zhang, Junyan ^{[2
]}

Zafarana, Gaetano ^{[2
]}

Pintilie, Melania ^{[2
]}

van der Kwast, Theodorus ^{[1
]}

Fraser, Michael ^{[2
]}

Boutros, Paul ^{[2
]}

Bristow, Robert G. ^{[2
]}

机构：

[1] Univ Toronto, Toronto, ON, Canada

[2] Princess Margaret Canc Ctr, Toronto, ON, Canada

[3] Ontario Inst Canc Res, Toronto, ON, Canada

[4] Univ Bern, Bern, Switzerland

[5] CHUQ, Quebec City, PQ, Canada

[6] Univ Laval, Quebec City, PQ, Canada

来源：

RADIOTHERAPY AND ONCOLOGY | 2016年 / 120卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

227

引用

页码：S82 / S83

页数：2

共 50 条

[31] Management of low- and intermediate-risk prostate cancer
van der Poel, Henk
Klotz, Laurence
Stief, Christian G.
WORLD JOURNAL OF UROLOGY, 2015, 33 (07) : 905 - 906
[32] Management of low- and intermediate-risk prostate cancer
Henk van der Poel
Laurence Klotz
Christian G. Stief
World Journal of Urology, 2015, 33 : 905 - 906
[33] Reoxygenation during radiotherapy in intermediate-risk prostate cancer
Supiot, Stephane
Rousseau, Caroline
Dore, Melanie
Cheze-Le-Rest, Catherine
Kandel-Aznar, Christine
Potiron, Vincent
Guerif, Stephane
Paris, Francois
Ferrer, Ludovic
Campion, Loic
Meingan, Philippe
Delpon, Gregory
Hatt, Mathieu
Visvikis, Dimitris
RADIOTHERAPY AND ONCOLOGY, 2019, 133 : 16 - 19
[34] REASSESSMENT OF RISK FACTORS FOR BIOCHEMICAL RECURRENCE IN D'AMICO INTERMEDIATE-RISK PROSTATE CANCER TREATED BY RADICAL PROSTATECTOMY
Narita, Shintaro
Mitsuzuka, Koji
Tsuchiya, Norihiko
Koie, Takuya
Kawamura, Sadafumi
Ohyama, Chikara
Tochigi, Tatsuo
Yamaguchi, Takuhiro
Arai, Yoichi
Habuchi, Tomonori
JOURNAL OF UROLOGY, 2016, 195 (04): : E712 - E713
[35] Importance of prostate volume in the stratification of patients with intermediate-risk prostate cancer
Moschini, Marco
Gandaglia, Giorgio
Suardi, Nazareno
Fossati, Nicola
Cucchiara, Vito
Damiano, Rocco
Cantiello, Francesco
Shariat, Shahrokh F.
Montorsi, Francesco
Briganti, Alberto
INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (06) : 555 - 561
[36] Prostate-specific antigen density predicts favorable pathology and biochemical recurrence in patients with intermediate-risk prostate cancer
Kang, Ho Won
Do Jung, Hae
Lee, Joo Yong
Kwon, Jong Kyou
Jeh, Seong Uk
Cho, Kang Su
Ham, Won Sik
Choi, Young Deuk
ASIAN JOURNAL OF ANDROLOGY, 2016, 18 (03) : 480 - 484
[37] TMPRSS2-ERG status and biochemical recurrence following radiotherapy for intermediate-risk prostate cancer
Dal Pra, Alan
Warde, Fiona
Ishkanian, Adrian Shea
Meng, Alice
Malloff, Chad
Lam, Wan
Sykes, Jenna
Pintile, Melania
Squire, Jeremy
van der Kwast, Theo
Evans, Andrew
Milosevic, Michael
Bristow, Robert Glen
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
[38] INTERMEDIATE-RISK PROSTATE CANCER, ANDROGEN DEPRIVATION THERAPY AND THE RISK OF DEATH
Pickles, Tom
Tyldesley, Scott
Keyes, Mira
Morris, W. James
RADIOTHERAPY AND ONCOLOGY, 2016, 120 : S27 - S27
[39] Brachytherapy for Intermediate-Risk Prostate Cancer, Androgen Deprivation, and the Risk of Death
Pickles, Tom
Tyldesley, Scott
Hamm, Jeremy
Virani, Sean A.
Morris, W. James
Keyes, Mira
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (01): : 45 - 52
[40] Development of prognostic signatures for intermediate-risk papillary thyroid cancer
Brennan, Kevin
Holsinger, Christopher
Dosiou, Chrysoula
Sunwoo, John B.
Akatsu, Haruko
Haile, Robert
Gevaert, Olivier
BMC CANCER, 2016, 16

← 1 2 3 4 5 →